This review assessed the ability of D-dimer tests to diagnose suspected deep vein thrombosis (DVT) and investigated reasons for differing results between studies. The authors concluded that a D-dimer test may be sufficient to rule-out proximal DVT, while its ability to rule-in DVT appears to depend on pre-test clinical probability (the test performs better in low-risk patients). The review was well conducted and reported and its conclusions are likely to be reliable.
Two reviewers independently screened titles and abstracts to identify potentially relevant articles. Full copies of all selected articles were retrieved. The same two reviewers then independently selected articles for inclusion. Kappa scores were calculated to measure agreement at both stages and any disagreements were resolved by consensus.
Assessment of study quality
Two reviewers independently assessed study quality using the following criteria: application of the reference standard independently of the D-dimer result; measurement of D-dimer blind to the result of the reference standard; conduct of the reference standard blind to the result of D-dimer testing; and use of a pre-determined diagnostic threshold for Ddimer rather than a threshold derived from the study data. An independent reviewer resolved any disagreements.
Data extraction
Two reviewers independently extracted the data using a standardised form. A third reviewer checked and resolved any discrepancies. Data were extracted on study and patient characteristics, the D-dimer assays and diagnostic thresholds used, reference standards used, true positives (proximal and distal), true negatives, false positives and false negatives (proximal and distal).
Methods of synthesis
How were the studies combined?
The results of the individual included studies were plotted in receiver operating characteristic space (true-positive rate versus false-positive rate). A random-effects model was used to estimate the overall sensitivity and specificity, with 95% confidence intervals (CIs). Where zero values occurred in the study data, a continuity correction of 0.5 was used. Analyses were conducted using MetaDiSc software.
Publication bias was assessed using funnel plots of the log odds of sensitivity and specificity against their corresponding standard errors.
How were differences between studies investigated?
Between-study heterogeneity was assessed using a chi-squared test. Initially, all studies were pooled and meta-regression was used to identify potential causes of heterogeneity in the sensitivity and specificity. Any covariate that showed an association with either sensitivity or specificity (p<0.1) was used to define subgroups for separate meta-analyses. In addition, subgroup analyses were conducted for: D-dimer assay method (ELISA, latex agglutination, whole-blood agglutination), proximal and distal DVT, individual D-dimer assays (by product name), patients with malignancy, and studies reporting results by Wells clinical risk stratification (see Other Publications of Related Interest).
Results of the review
Ninety-seven studies, with a total of 99 patient groups and 198 analyses of D-dimer assays, were included in the review.
Study quality.
The reference standard was applied independently of the results of D-dimer testing in 86 studies. D-dimer was measured blind to the results of the reference standard in 43 studies, and the reference standard was conducted blind to the results of D-dimer testing in 50 studies. The diagnostic threshold for D-dimer was defined a priori in 82 studies.
Diagnostic accuracy.
For all included studies, the sensitivity of the D-dimer test ranged from 48 to 100% and its specificity ranged from 5 to 100%. There was significant heterogeneity in both parameters (p<0.001).
Investigation of heterogeneity.
A number of covariates showed significant association with variation in sensitivity and/or specificity. These included methodological characteristics of the studies, participant characteristics, and aspects of the reference standard and index test methodology; they were reported in full in the paper. Subgroup analyses using groups identified by meta-regression indicated that studies using more selective patient groups tended to have higher sensitivity and specificity, while higher quality studies tended to have higher specificity and studies deriving the diagnostic threshold for D-dimer after data analysis tended to have higher sensitivity. However, significant heterogeneity remained after stratification. The results were reported in full.
Subgroup analyses.
For ELISA (91 analyses), the pooled sensitivity was 94% (95% CI: 93, 95) and the pooled specificity was 45% (95% CI: 44, 46). For latex agglutination assays (74 analyses), the pooled sensitivity was 89% (95% CI: 88, 90) and the pooled specificity was 55% (95% CI: 54, 56). For whole-blood agglutination assays (29 analyses), the pooled sensitivity was 87% (95% CI: 85, 88) and the pooled specificity was 68% (95% CI: 67, 69). Heterogeneity was not reported for these subgroups. An analysis of studies that reported proximal and distal DVT separately showed that all assays had higher sensitivity for proximal DVT. An analysis of studies that stratified participants by Wells clinical risk score indicated that the specificity of D-dimer may be dependent on the clinical probability of DVT (increasing with decreasing clinical risk). Significant heterogeneity remained within the subgroups, which could not be eliminated by further stratification to individual D-dimer assays; the results were reported in full.
Publication bias.
The funnel plots appeared symmetrical for specificity, but markedly asymmetrical for sensitivity. Few small studies reported low sensitivity, indicating that small studies with low sensitivities may be less likely to be published (specificity is less likely to influence publication in this way as a D-dimer assay is unlikely to be used to rule-in DVT).
